Introduction
Primary spinal tumors (PST) should be considered in cases of a solitary spinal lesion. A wide variety of primary neoplasms can involve the spine. Spinal tumors can be classified according to their tissue of origin. [1] Patients' symptoms may be insidious and non-specific. [2] They are either intradural, intramedullary, or intradural extramedullary. [3] PST in children remains a vexing clinical problem as its existence is often unrecognized until occurrence of spinal cord compression. monitor all cases. Resection of the tumor by multi-level laminectomy or laminoplasty was performed in all cases. For hemangioblastomas and small-to moderately-sized ependymomas, the tumors were resected using an outside-in technique, with en bloc removal when identification of tumorspinal cord transition plane was clear.
The primary outcome measured was survival. Patients were considered to have an event at time of death from any cause; survivors were censored at last follow-up. Research ethics board approval was obtained, with patient consent not required for this retrospective study with de-identified subjects. All patients had a pathologic diagnosis and were grossly evaluated for focal hemorrhage, cystic change, and myxoid change. No personal identifiers were included in the electronic database.
Results

Patient population
We retrospectively reviewed the records of 22 consecutive pediatric patients seen at a single institution from 1997 to present patients newly diagnosed with PST. There were 12 boys and 10 girls, with a male-to-female ratio of 1.2:1. The median age at diagnosis was 12.2 years, with a range of 2 weeks up to 17.9 years. The median duration of symptoms before diagnosis was 2 months (0.5-48). All patients were followed-up for a median of 80 months. The most common clinical presentation was limb weakness (52%) followed by back pain (29%) [ Table 1 ]. Location of the tumor was intradural, intramedullary in 10 patients, and intradural extramedullary in 12 patients. Intramedullary tumors comprised predominantly of gliomas (infiltrative astrocytomas and ependymomas). There were no patients with neurofibromatosis type 2 in this series.
Seven tumors were located primarily in the cervical cord (2 hemangiomas, 2 neurofibromas, 1 ependymoma, 1 Langerhans cell histiocytosis, and 1 astrocytoma), 10 were predominantly thoracic (3 astrocytomas, 2 mesenchymal chondrosarcomas, 4 neurilemomas, 1 hemangioma), 4 lumbar (2 myxopapillary ependymoma, 1 teratoma, 1 primitive neuroectodermal tumor (PNET)), and 1 sacral teratoma.
Surgical results
All patients underwent laminectomy for removal of tumor. GTR of tumors was achieved in 15 of 22 patients (68%), subtotal resection in 2 patients (9%), partial resection in 3 patients (14%), and biopsy in 2 patients (9%). A GTR was more frequently achieved in cases of teratoma, mesecnhymal chondrosarcoma, and neurillemoma. An example of GTR is shown in Figure 1 . Table 2 shows the location and extent of tumors, and their pathologic classification.
Complications
There were no operative deaths. One patient with astrocytoma succumbed to tumor progression and one with plexiform neurofibroma subsequently died of malignant peripheral nerve sheath tumor, although chemotherapy and radiotherapy had been attempted (patients 6, 13).
Post-operative adjuvant therapy
Most patients (59%) did not receive post-operative radiotherapy or chemotherapy. Seven patients received adjunctive spinal irradiation as part of the initial treatment, with doses ranging from 4600 to 6120 cGy. Five patients received adjuvant chemotherapy for their primary tumor. Salvage chemotherapy was administered after radiotherapy in two patients.
Five patients (patients 8, 9, 10, 13, 22) were treated with six courses of cisplatin and etoposide. One patient (patient 22) developed lung metastasis 2 years after the diagnosis of PNET of the sacrum and died of progressive disease despite receiving high dose chemotherapy with autologous stem cell rescue. At the time of analysis, the median progression-free survival in these patients was 105 months, and the median survival was 99 months.
Discussion
Owing to the relative rarity of PST, optimal therapy has yet to be determined. [4, 5] Extramedullary intradural tumors are the most common spinal cord tumors in adult, [6] whereas intramedullary tumors constitute about 35% of the spinal tumors found in children. [7, 8] Low-grade gliomas such as ependymomas and astrocytomas account for vast majority. [9] Intramedullary tumors infrequently progress slowly and for a long time often with rather mild symptoms and ill-defined pain.
PSTs produce symptoms due to compression of nerve root or cord, and ischemia vascular compression. The clinical symptoms are invariably non-specific. Limb weakness is often the leading symptom. Tethering of the cord by the dentate ligaments and filum terminale may result when expanding lesions oppose this resistance. The main symptoms are pain, weakness, sensory disturbance, and autonomic disturbances. In addition, there may be a vertebral deformity, especially in children.
Intramedullary tumors are predominantly intrinsic gliomas (astrocytomas and ependymomas). Spinal ependymomas are more common and often can be completely removed by separating the tumor from the spinal cord and when complete no further therapy is required. However, astrocytomas infiltrate the myelon and complete resection is rare. Intradural extramedullary tumors include schwannomas, neurofibromas, and meningiomas and are usually amenable to surgical resection.
The thoracic spine is more commonly involved than the lumbar or cervical spine. In our study, the most common clinical presentation is limb weakness which is usually splastic. The treatment of PST in children is primarily surgical. [10] [11] [12] A GTR was possible in 15 of our patients. Highly malignant aggressive neoplasms of PST are rare in children. [2, 13] GTR should be the preferred treatment in symptomatic patients. Serial imaging is recommended to guide subsequent resection for tumor recurrence and stabilization of progressive spinal deformity.
Conclusions
This is a retrospective study of a moderate size of pediatric PST with a wide range of follow-up time. Being a rare disease entity with a discrete pathology and symptomology, it is obviously premature to draw an astounding statistical conclusion from this study. As such, one must be vigilant to possible signs of spinal cord compression. According to our analytical study, it is concluded that total resection of pediatric PST can be achieved with low incidence of neurological injury.
